Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Evaluation of 3,3'-diindolylmethane with gardasil quadrivalent HPV vaccine in K14-HPV16-transgenic mice cervical histology.

Sepkovic DW, Pagan DV, Stein J, Carlisle AD, Ksieski HB, Auborn K, Nyirenda T, Bradlow HL.

In Vivo. 2013 May-Jun;27(3):299-304.

PMID:
23606684
2.

Polychlorinated biphenyl exposure, diabetes and endogenous hormones: a cross-sectional study in men previously employed at a capacitor manufacturing plant.

Persky V, Piorkowski J, Turyk M, Freels S, Chatterton R Jr, Dimos J, Bradlow HL, Chary LK, Burse V, Unterman T, Sepkovic DW, McCann K.

Environ Health. 2012 Aug 29;11:57.

3.

3,3'-Diindolylmethane increases serum interferon-╬│ levels in the K14-HPV16 transgenic mouse model for cervical cancer.

Sepkovic DW, Raucci L, Stein J, Carlisle AD, Auborn K, Ksieski HB, Nyirenda T, Bradlow HL.

In Vivo. 2012 Mar-Apr;26(2):207-11.

PMID:
22351660
4.

Anti-proliferative effects of Chinese herb Cornus officinalis in a cell culture model for estrogen receptor-positive clinical breast cancer.

Telang NT, Li G, Sepkovic DW, Bradlow HL, Wong GY.

Mol Med Rep. 2012 Jan;5(1):22-8. doi: 10.3892/mmr.2011.617.

PMID:
21971582
5.
6.

Results from a dose-response study using 3,3'-diindolylmethane in the K14-HPV16 transgenic mouse model: cervical histology.

Sepkovic DW, Stein J, Carlisle AD, Ksieski HB, Auborn K, Raucci L, Nyirenda T, Bradlow HL.

Cancer Prev Res (Phila). 2011 Jun;4(6):890-6. doi: 10.1158/1940-6207.CAPR-10-0369.

7.

3,3'-diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study.

Rajoria S, Suriano R, Parmar PS, Wilson YL, Megwalu U, Moscatello A, Bradlow HL, Sepkovic DW, Geliebter J, Schantz SP, Tiwari RK.

Thyroid. 2011 Mar;21(3):299-304. doi: 10.1089/thy.2010.0245.

8.

Effects of a breast-health herbal formula supplement on estrogen metabolism in pre- and post-menopausal women not taking hormonal contraceptives or supplements: a randomized controlled trial.

Laidlaw M, Cockerline CA, Sepkovic DW.

Breast Cancer (Auckl). 2010 Dec 16;4:85-95. doi: 10.4137/BCBCR.S6505. Erratum in: Breast Cancer (Auckl). 2012;6:101.

9.

Diindolylmethane inhibits cervical dysplasia, alters estrogen metabolism, and enhances immune response in the K14-HPV16 transgenic mouse model.

Sepkovic DW, Stein J, Carlisle AD, Ksieski HB, Auborn K, Bradlow HL.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2957-64. doi: 10.1158/1055-9965.EPI-09-0698. Erratum in: Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):628.

10.

Lycium barbarum inhibits growth of estrogen receptor positive human breast cancer cells by favorably altering estradiol metabolism.

Li G, Sepkovic DW, Bradlow HL, Telang NT, Wong GY.

Nutr Cancer. 2009;61(3):408-14. doi: 10.1080/01635580802585952.

PMID:
19373615
11.

Dietary seaweed modifies estrogen and phytoestrogen metabolism in healthy postmenopausal women.

Teas J, Hurley TG, Hebert JR, Franke AA, Sepkovic DW, Kurzer MS.

J Nutr. 2009 May;139(5):939-44. doi: 10.3945/jn.108.100834. Erratum in: J Nutr. 2009 Sep;139(9):1779.

12.

Estrogen hydroxylation--the good and the bad.

Sepkovic DW, Bradlow HL.

Ann N Y Acad Sci. 2009 Feb;1155:57-67. doi: 10.1111/j.1749-6632.2008.03675.x. Review.

PMID:
19250192
13.

Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11.

Dhar M, Sepkovic DW, Hirani V, Magnusson RP, Lasker JM.

J Lipid Res. 2008 Mar;49(3):612-24.

14.

Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer.

Greenlee H, Chen Y, Kabat GC, Wang Q, Kibriya MG, Gurvich I, Sepkovic DW, Bradlow HL, Senie RT, Santella RM, Ahsan H.

Breast Cancer Res Treat. 2007 Mar;102(1):111-7.

PMID:
16850246
15.

A hormonal association between estrogen metabolism and proliferative thyroid disease.

Chan EK, Sepkovic DW, Yoo Bowne HJ, Yu GP, Schantz SP.

Otolaryngol Head Neck Surg. 2006 Jun;134(6):893-900.

PMID:
16730526
16.

Estrogen metabolism and breast cancer.

Kabat GC, O'Leary ES, Gammon MD, Sepkovic DW, Teitelbaum SL, Britton JA, Terry MB, Neugut AI, Bradlow HL.

Epidemiology. 2006 Jan;17(1):80-8.

PMID:
16357599
17.

Urinary estrogen metabolites, prostate specific antigen, and body mass index among African-American men in South Carolina.

Teas J, Cunningham JE, Fowke JH, Nitcheva D, Kanwat CP, Boulware RJ, Sepkovic DW, Hurley TG, Hebert JR.

Cancer Detect Prev. 2005;29(6):494-500.

PMID:
16289388
18.

A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio.

Paracchini V, Pedotti P, Raimondi S, Garte S, Bradlow HL, Sepkovic DW, Taioli E.

Clin Chem Lab Med. 2005;43(7):702-6.

PMID:
16207128
19.

Comparison of plasma and urinary levels of 2-hydroxyestrogen and 16 alpha-hydroxyestrogen metabolites.

Bradlow HL, Jernstr├Âm H, Sepkovic DW, Klug TL, Narod SA.

Mol Genet Metab. 2006 Feb;87(2):135-46.

PMID:
16165383
20.

Urinary estrogen metabolites and their ratio among Asian American women.

Falk RT, Fears TR, Xu X, Hoover RN, Pike MC, Wu AH, Nomura AM, Kolonel LN, West DW, Sepkovic DW, Bradlow HL, Ziegler RG.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):221-6.

Items per page

Supplemental Content

Loading ...
Support Center